Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
CorMedix Inc. (CRMD)
Market Closed
17 Jul, 20:00
NASDAQ (NMS)
All
(5)
DE
(4)
US
(1)
NASDAQ (NMS)
Primary
XFRA
XMUN
XSTU
XDUS
$
8.
42
+0.13
+1.5682%
$
659M
Market Cap
-
P/E Ratio
-
Div Yield
679,089
Volume
-0.83
Eps
$
8.29
Previous Close
Investors:
JD
ME
BG
NM
+24
Watching
Watch
Add Transaction
Day Range
8.14
8.53
Year Range
6.13
14.96
Want to track
CRMD
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Splits
Statistics
News
Historical Data
Investors
CorMedix Inc. (CRMD) Statistics
Valuation metrics
Market Cap
659M
Enterprise value
629.89M
Trailing P/E (ttm)
3.54
Forward P/E
11.26
PEG ratio
0
Price/Sales (ttm)
1.65
Price/Book (mrq)
1.53
Enterprise Value/Revenue
1.57
Enterprise Value/EBITDA
2.96
Overview
Shares outstanding
79.26M
Float
68.04M
Shares short
16.22M
% Held by insiders
0.08%
% Held by institutions
0.57%
Average volume (10 days)
793.38K
Average volume (90 days)
1.3M
Price summary
52-Week low
6.13
52-Week high
14.96
Beta
1.46
50-Day moving average
8.42
200-Day moving average
7.71
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:5
Last split Date
26 Mar 2019
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.45%
Operating margin
0.48%
Operational effectiveness
Return on assets
0.22%
Return on equity
0.5%
Income Statement
Revenue (ttm)
311.71M
Revenue per share (ttm)
5.03
Quarterly revenue growth (yoy)
3.12%
Gross profit (ttm)
289.62M
EBITDA
168.54M
Net income to common (ttm)
162.07M
Diluted EPS (ttm)
2.28
Quarterly earnings growth (yoy)
0.04%
Balance Sheet
Total cash (mrq)
148.53M
Total cash per share (mrq)
2.24
Total debt (mrq)
148.91M
Total Debt/Equity (mrq)
0.34
Current ratio (mrq)
2.98%
Book value per share (mrq)
5.5
Cash Flow
Cash flow statement
175.05M
Levered free cash flow (LFCF)
108.51M